Diabetes in Control Special Report
March 15, 2010

Exenatide Once Weekly -- FDA Update
David Joffe, BSPharm, CDE, FACA

Amylin, Lilly and Alkermes received a Complete Response Letter from FDA for Exenatide Once Weekly. New drug to be called BYDUREON (exenatide for extended-release injectable suspension).

To learn what Amylin has to do and what it all means, read the full story.